EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 4.0

Clinical impact of medication review and deprescribing in older inpatients: A systematic review and meta‐analysis

Massimo Carollo iD, Salvatore Crisafulli, Giacomo Vitturi, Matilde Besco, Damiano Hinek, Andrea Sartorio, Valentina Tanara, Giulia Spadacini, Margherita Selleri, Valentina Zanconato, Cristiano Fava, Pietro Minuz und 2 weitere

Journal of the American Geriatrics Society · 2024-10 · 72 (10) · 3219-3238

DOI: 10.1111/jgs.19035 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of the American Geriatrics Society, 2024-06. Verfasst von Massimo Carollo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostics and Public Health, Clinical Pharmacology Unit, University of Verona, Verona, Italy. Hauptthemen laut MEDLINE: Deprescriptions, Polypharmacy, Inappropriate Prescribing. Die Arbeit wurde bisher 113-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Polypharmacy is a primary risk factor for the prescription of potentially inappropriate medications (PIMs), drug–drug interactions (DDIs), and ultimately, adverse drug reactions (ADRs). Medication review and deprescribing represent effective strategies to simplify therapeutic regimens, minimize risks, and reduce PIM prescriptions. This systematic review and meta‐analysis of experimental and observational studies aimed to evaluate the impact of different medication review and deprescribing interventions in hospitalized older patients.

Methods

Experimental and observational prospective cohort studies evaluating the clinical effects of medication review and deprescribing strategies in older hospitalized patients were searched in the bibliographic databases, PubMed, Embase, and Scopus, from inception until January 8, 2024. A narrative synthesis of the results was provided, along with a meta‐analysis of dichotomous data (i.e., re‐hospitalizations and mortality).

Results

Overall, 21 randomized controlled trials, 7 non‐randomized interventional studies, and 2 prospective cohort studies were included in the systematic review. Of these, 14 (46.7%) assessed medication appropriateness as the primary outcome, while the remaining evaluated clinical outcomes (e.g., length of hospital stay, hospital readmissions, emergency department visits, and incidence of ADRs) and/or quality of life. The meta‐analysis revealed a slight but statistically significant 8% reduction in hospital readmissions (HR: 0.92; 95% CI: 0.85–0.99) following medication review and deprescribing, but no significant impact on mortality (HR: 0.98; 95% CI: 0.96–1.00). Of the 30 included studies, 21 were considered at high risk of bias, mostly due to potential deviations from intended interventions and randomization processes. The remaining nine studies had “some concerns” (eight studies) or were considered at “low” risk of bias (one study).

Conclusion

Medication review and deprescribing are associated with potential benefits in reducing hospital readmission rates among hospitalized older patients, particularly through the reduction of PIM prescriptions. The integration of thorough medication review and deprescribing protocols in hospital settings may improve post‐discharge outcomes and reduce overall healthcare costs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DeprescriptionsPolypharmacyInappropriate PrescribingHumansAgedHospitalizationPotentially Inappropriate Medication ListInpatientsDrug-Related Side Effects and Adverse ReactionsDrug InteractionsAged, 80 and overProspective StudiesPatient Readmission

Stichwörter der Autor:innen

deprescribingmedication reviewmultimorbiditypatient‐centered carepolypharmacy

Autor:innen und Institutionen

  • Department of Diagnostics and Public Health, Clinical Pharmacology Unit, University of Verona, Verona, Italy.
  • Department of Medicine, University of Verona, Verona, Italy.
  • Department of Medicine, Geriatrics Division, University of Verona, Verona, Italy.
  • Department of Pharmacy, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
  • Department of Medicine, Section of Internal Medicine C, University of Verona, Verona, Italy.
  • Department of Surgery, Dentistry, Pediatric and Gynecology, Section of Geriatric Medicine, University of Verona, Verona, Italy.

ORCID-Profile: Massimo Carollo

Zitieren

APA

Carollo, M., Crisafulli, S., Vitturi, G., Besco, M., Hinek, D., Sartorio, A., Tanara, V., Spadacini, G., Selleri, M., Zanconato, V., Fava, C., Minuz, P., Zamboni, M., & Trifirò, G. (2024). Clinical impact of medication review and deprescribing in older inpatients: A systematic review and meta‐analysis. Journal of the American Geriatrics Society, 72(10), 3219-3238. https://doi.org/10.1111/jgs.19035

Vancouver

Carollo M, Crisafulli S, Vitturi G, Besco M, Hinek D, Sartorio A, et al. Clinical impact of medication review and deprescribing in older inpatients: A systematic review and meta‐analysis. Journal of the American Geriatrics Society. 2024;72(10):3219-3238. doi:10.1111/jgs.19035

BibTeX
@article{Carollo2024,
  author = {Carollo, Massimo and Crisafulli, Salvatore and Vitturi, Giacomo and Besco, Matilde and Hinek, Damiano and Sartorio, Andrea and Tanara, Valentina and Spadacini, Giulia and Selleri, Margherita and Zanconato, Valentina and Fava, Cristiano and Minuz, Pietro and Zamboni, Mauro and Trifirò, Gianluca},
  title = {Clinical impact of medication review and deprescribing in older inpatients: A systematic review and meta‐analysis},
  journal = {Journal of the American Geriatrics Society},
  year = {2024},
  volume = {72},
  number = {10},
  pages = {3219--3238},
  doi = {10.1111/jgs.19035}
}
Kostenlos starten →